Brixadi® is the only once-weekly and once-monthly injectable buprenorphine long-acting medication for the treatment of moderate to severe opioid use disorder. Brixadi® offers flexible dosing options to support individualized care and improve treatment adherence. This chapter provides clinical pearls on how to appropriately prescribe and administer Brixadi®.